Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark

1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

1

Trials led

0

Active

0

Total enrollment

1

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2/3
1

Trials by status

Withdrawn
1

Trials led

TOTTPh 2/3Withdrawnnot disclosed